Antibody-based therapies for emerging infectious diseases.
about
Wanted, dead or alive: New viral vaccinesPreparation of commercial quantities of a hyperimmune human intravenous immunoglobulin preparation against an emerging infectious disease: the example of pandemic H1N1 influenza.Using monoclonal antibodies to prevent mucosal transmission of epidemic infectious diseases.Controlled-release and local delivery of therapeutic antibodies.The versatile roles of antibodies in Borrelia infections.Parasites and immunotherapy: with or against?A "Double-Edged" Scaffold: Antitumor Power within the Antibacterial Quinolone.An assessment of the future impact of alternative technologies on antibiotics markets.Novel strategies for controlling Streptococcus pyogenes infection and associated diseases: from potential peptide vaccines to antibody immunotherapy.Clinical applications of intravenous immunoglobulins (IVIg)--beyond immunodeficiencies and neurology.Targeting the "cytokine storm" for therapeutic benefit.What if there were no new antibiotics? A look at alternatives.Antibody-based therapies as anti-infective agents.Current pathogenic Escherichia coli foodborne outbreak cases and therapy development.Metal-Based Nanoparticles for the Treatment of Infectious Diseases.Prophylactic treatment of gram-positive and gram-negative abdominal implant infections using locally delivered polyclonal antibodies.New antibacterials?The Capsular Polysaccharide of Acinetobacter baumannii Is an Obstacle for Therapeutic Passive Immunization Strategies.The Annexin A1 Receptor FPR2 Regulates the Endosomal Export of Influenza Virus.Evolution of Therapeutic Antibodies, Influenza Virus Biology, Influenza, and Influenza Immunotherapy.Broadly neutralizing antibodies in HIV-1 treatment and prevention
P2860
Q27489979-1FA63E7A-E372-40FE-BD80-875727A5159AQ30407946-AC6E12E7-5E37-4C3E-A214-0A575897F309Q33542433-82BF57C8-87C0-4ECF-9178-2560DB22A4D8Q35842644-391577FD-7573-4854-9A7E-4D3DD3426C8DQ36111888-BF7567B4-8F7A-4FBB-910F-F65108C1EA17Q37053248-4A6B17CE-BB2A-426E-86F5-FC71DB76B91DQ37204002-FB7F2651-4A7D-42AA-8CBB-94FEF7167989Q37367183-C598A20B-1175-4B42-9FB1-66D549AC80C9Q37471470-905D8B5B-1E81-4B14-8B9F-FDF594914C8BQ37626123-7AEFAB14-1B33-4DAB-BADD-12EF8AF794C2Q38071254-08F17B2F-20EF-414E-B5EC-07FE9DAD512AQ38966367-3641D88B-9EF0-4425-9436-E94CCE3952E3Q39216839-A8A92B3B-E711-4B15-BEE7-68087C6F2480Q39361401-E189D8CD-6E09-4D89-9BD0-84D693BA3E6DQ40078347-8677AC25-4CB6-49A3-AD85-920BBEA23AEBQ42163203-8F522C05-6310-4AF5-9AD0-3E5ACA6342B8Q42656459-8E30F9F8-C59F-4BE4-8A04-BC71F9B9CC0BQ47744180-5AD4D57C-46A2-4B6C-87EA-CDD7E969DBE1Q55080745-E23D7E0F-157F-4AE1-B273-9C1E05E57F2AQ55554478-9342EB90-0654-479D-A0D5-C8D9526159E5Q57815702-9C960EB1-C551-4263-94E3-3F5EEFE83B19
P2860
Antibody-based therapies for emerging infectious diseases.
description
1996 nî lūn-bûn
@nan
1996年の論文
@ja
1996年論文
@yue
1996年論文
@zh-hant
1996年論文
@zh-hk
1996年論文
@zh-mo
1996年論文
@zh-tw
1996年论文
@wuu
1996年论文
@zh
1996年论文
@zh-cn
name
Antibody-based therapies for emerging infectious diseases.
@en
Antibody-based therapies for emerging infectious diseases.
@nl
type
label
Antibody-based therapies for emerging infectious diseases.
@en
Antibody-based therapies for emerging infectious diseases.
@nl
prefLabel
Antibody-based therapies for emerging infectious diseases.
@en
Antibody-based therapies for emerging infectious diseases.
@nl
P2860
P921
P356
P1476
Antibody-based therapies for emerging infectious diseases.
@en
P2093
A Casadevall
P2860
P304
P356
10.3201/EID0203.960306
P577
1996-07-01T00:00:00Z